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Objective: to report our experience with 21 consecutive patients treated with a thoracic stent-graft.
Design: retrospective analysis.
Materials and Methods: Between October 1998 and February 2002, 21 patients (12 male), mean age 55.6 years (range
19±86 years), were treated for aorticortic pathology localized to the descending aorta (18 patients), the aortic arch
(2 patients) and the ascending aorta (1 patient) and comprising true aneurysms (8 patients), false aneurysms (6 patients),
traumatic rupture (4 patients), mycotic aneurysms (2 patients), and ruptured aneurysm (1 patient). Plain chest X-rays and
computed tomography was performed at 3, 6 and 12 months postoperatively and then annually.
Results: the median (range) operation time was 85 min (50±305 min), hospital stay 6 days (3±63 days) and follow-up 24
months (5±44 months). Complications occurred in 5 patients and comprised intraoperative migration (1), type I endoleak
(1), type II endoleak (1), ischemic myelopathy (1), pneumonia (2), suture granuloma (1) and common femoral artery
dissection (1).
Conclusions: stent-grafting can be successfully employed to treat a wide range of thoracic aortic pathologies with a
mortality, morbidity and resource utilization that is considerably less than that associated with conventional surgery.
However, long term follow-up on safety and efficacy is needed.
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Introduction
Surgical treatment of thoracic aortic aneurysms was
first described by DeBakey in 1953.1 During the last
several decades the mortality of this procedure has
dropped significantly from approximately 20% in the
1960s2 to 2±3% nowadays.3 These are however the
most favorable results in literature.4
Only 10 years ago a new minimally invasive tech-
nique for treating aortic aneurysms, transfemoral
placement of an endovascular graft, was introduced
by Volodos5 and Parodi.6 The stent-graft technique
has mainly been used for the treatment of abdom-
inal aortic aneurysms but, from the start it was
evident that it could also be used for thoracic aortic
pathology.5±8
Nowadays, the thoracic aortic stent-graft is used
for treating a variety of aortic pathologies such
as aneurysms,9±11 traumatic ruptures12±15 and
dissections.11,16±18
It has been shown that the endovascular procedure
reduces morbidity and mortality when compared to
open repair.19 In this paper we describe the feasibility
and mid-term results of thoracic stent-grafts in 21
consecutive patients treated either electively or
acutely with a thoracic endovascular stent-graft
between October 1998 and February 2002.
Materials and Methods
Patient selection
Patients were selected based on spiral computed tomo-
graphy (CT) angiography.20 Patients were considered
anatomically suitable if there was a proper anchoring
site for the stent-graft both proximal and distal to the
aortic lesion. These anchoring sites should have a
maximum diameter of 36 mm and a minimum length
of 10 mm, with the distal anchoring site cranial to the
visceral arteries. Furthermore, access through the
abdominal aorta either by a transfemoral route or by
direct exposure of an iliac artery or the abdominal
aorta should be feasible.
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Preoperative imaging
Our imaging protocol consisted of contrast enhanced
spiral CT angiography with use of dedicated post
processing software (Mx View V3.51, Marconi Medical
Systems). The scan delay time was determined based
on a `` delay test run''. This is followed by a series
without contrast (120 kV, 150 mA s, increment 10,
thickness 10, pitch 1.25, filter C, window W300, C30)
and a contrast series (0.5 s rotation time, 120 kV,
200 mA s, increment 2.5, thickness 5, pitch 1.25, filter
B, window W300, C70). Typically, we would construct
a central lumen line in the aorta and perform diameter
measurements in planes reconstructed perpendicular
to this vascular axis.21 Length measurements were
also calculated based on the central lumen line and
no additional angiography was performed prior to
surgery. In complex patients, e.g. pathology in the
aortic arch, additional Shaded Surface Projections
(SSP) were reconstructed to help us understand the
anatomy. Patients with emergency indications, e.g.
traumatic aorta ruptures, were treated based on
quick analysis of the axial CT images and the intra-
operative angiography.
Stent-grafts
Three makes of stent-grafts have been used: the
GoreTM Thoracic Aortic Graft (W.L. Gore & Associates,
AZ, U.S.A.) in 17 patients, the TalentTM thoracic
endoprosthesis (Medtronic AVE, Ca, U.S.A.) in
3 patients and the AneuRxTM stent-graft (Medtronic
AVE, Ca, U.S.A.) in 1 patient. For optimal fixation a
minimum of 20% oversizing of the stent-graft diam-
eter as compared to the diameter of the anchoring site
in the aorta was applied. In total, 28 stent-grafts
(median length 12.0 cm (range 7.5±15.0 cm), median
diameter 3.4 cm (range 2.6±4.0 cm) were placed in 21
patients; in 18 patients we placed 1 stent-graft, in 3
patients we placed 2 stent grafts. In 2 patients stent-
grafts were placed in both the thoracic and abdominal
aorta in one operation.
Endovascular procedure
All procedures were performed by a vascular surgeon
and an interventional radiologist under general
anesthesia. Vascular access was preferably gained
through surgical exposure of the right common fem-
oral artery and placement of a 7 french sheath (Cordis,
Miami, FL, U.S.A.). Preoperative imaging was per-
formed using a mobile C-arm (Exposcop 8000,
ZIEHM GmbH, Neurnberg, Germany, later replaced
by the OEC 9800 mobile intensifier, GE Medical
Systems, Salt Lake City, U.S.A.). A double J guide-
wire and 5 french 90 cm pigtail catheters (Altaflow,
Optimed, Ettlinger, Germany) were positioned in the
ascending aorta, with subsequent replacement by a
heavy-duty guide-wire (Back-up Meier, Boston
Scientific-Schneider, BuÈ lach, Switzerland). In patients
with aneurysms in the ascending aorta or aortic arch
an additional angiography catheter was inserted in
the ascending aorta through the right brachial artery
and intermittent contrast injections were made prior
to and during graft deployment. If required, the stent-
grafts could be gently dilated at the proximal and
distal anchoring zones using a compliant balloon. At
the end of the procedure a completion angiography
was made to confirm aneurysm exclusion and assess
possible endoleaks.
Follow-up
Follow-up consisted of 4 directional (anterior±posterior,
lateral and 2 oblique) plain chest X-rays and CT angio-
graphy with contrast enhancement followed by
delayed scanning 1 min after completion of the con-
trast series (120 kV, 200 mA s, 0.75 rotation time, incre-
ment 5, thickness 5, pitch 1.25, filter B, Window W300,
C50) to improve endoleak detection.22 Success was
defined as succesful exclusion of the aneurysm.23
Follow-up was performed at 3, 6 and 12 months post-
operatively and yearly thereafter.
Results
General results
Between October 1998 and February 2002, 21 consecu-
tive patients (12 male, 9 female) with a mean age of
55.6 years (range 19±86 years) underwent endovascu-
lar treatment of the thoracic aorta. All consecutive
patients are listed in Table 1.
The aortic pathology was mainly localized in the
descending aorta (18 patients), followed by the aortic
arch (2 patients) and ascending aorta (1 patient). Four
traumatic aortic ruptures were located in either the
isthmus or proximal descending aorta. In all
patients implantations were performed through the
transfemoral route; except for patient 1, where a retro-
peritoneal route was used because of occlusion of the
left, and subtotal stenosis of the right iliac artery. The
stent-graft could successfully be placed in all patients.
Median duration of the endovascular procedure was
85 min (50±305 min).
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In 3 patients we created a carotid-to-subclavian
artery bypass. In two of these the aortic stent-graft
intentionally covered the origin of the left subclavian
artery in order to increase the proximal sealing zone
for the endograft. This resulted in decreased blood
pressure in the ipsilateral arm. In the other patient
the aneurysm originated from a previous endarterect-
omy of part of the aortic arch and subclavian artery.
Median duration of hospital stay was 6 days (3±63
days). No patient died as a result of complications of
endovascular treatment during 24 months mean
follow-up (range 5±44 months). Mid-term results are
summarized in Table 2. No immediate conversion to
conventional open thoracic aortic surgery was needed.
There were several indications for endovascular
treatment: 8 patients had an aneurysm of the descend-
ing thoracic aorta (TAA) (Fig. 1a and b). The median
age was 59.5 years (range 48±86 years). In 3 of these
patients, 2 stent-grafts were used for aneurysm exclu-
sion. Median operation time was 65 min (range
60±305 min). In patient 9 (operation time 175 min) we
implanted an additional stent-graft for an abdominal
aortic aneurysm. In patient 11 we performed a left
sided carotid-axillary bypass, because of extension of
the aneurysm up to the subclavian artery. Stent
deployment was complicated by migration and a
subsequent type I endoleak which was resolved by
implanting a second stent-graft during the same
procedure.
Six patients were treated with a stent-graft for a
false aneurysm. Three of these patients had a previous
operation for aortic coarctation. Patient 1, a 71-year-
old female, developed a 9 cm asymptomatic aneurysm
accompanied by an occlusion of the left subclavian
artery. Due to severe preexisting pulmonary problems,
the patient 1 was regarded inoperable by her pulmo-
nologist, and was then successfully treated with an
aortic stent-graft. Patient 2 had an aneurysm just
1 cm distal from the origin of the left subclavian artery.
We chose to place the stent-graft covering the sub-
clavian artery to obtain a good anchoring position.
At 3 months, a persisting postoperative disabling left
arm claudication caused by a subtotal stenosis of the
Table 2. Mid-term results.
Number of patients 21
Follow-up (mean and range) months 24 (5±44)
Successful exclusion of aneurysm or rupture 18
Open surgical repair 1
Type I endoleak (treated successfully) 1
Type II endoleak (persistent) 1
Early mortality 0
Late mortality (not aneurysm/rupture related) 1
PTA of origin of subclavian artery 1
Surgical drainage of aneurysm sac hygroma 1
Table 1. Patient and operative characteristics.
Pat/Gen/Age Prev. History Pathology Localisation Access Stent-
grafts (n)
Op. time
(min)
Hospital
stay (days)
Follow-up
(months)
1/F/71 Coarctatio aortae False Descending Retro-
peritoneal
1 125 9 44
2/M/48 Coarctatio aortae False Descending CFA 1 120 9 40
3/F/63 Stenosis subclavian
artery
False Arch CFA 1 200 8 40
4/F/65 ± TAA Descending CFA 1 60 4 38
5/F/55 ± TAA Descending CFA 1 60 3 38
6/M/48 ± TAA Descending CFA 2 60 36 38
7/M/64 ± TAA Descending CFA 2 175 4 31
8/F/65 ± Myc.TAA Descending CFA 1 85 63 27
9/F/61 ± Myc.TAA Arch/Descending CFA 1 250 16 27
10/M/44 Marfan; Bentall False Ascending CFA 1 75 4 26
11/M/72 ± TAA Descending CFA 2 305 4 24
12/M/19 ± Traum. Rupture Descending CFA 1 110 21 24
13/M/53 ± Traum. Rupture Descending CFA 1 60 24 9
14/M/51 ± TAA Descending CFA 1 85 3 20
15/M/30 Coarcatio aortae False Descending CFA 1 255 4 18
16/M/44 ± Traum. Rupture Descending CFA 1 50 55 16
17/F/40 Marfan; Scoliosis False Descending CFA 1 59 5 13
18/M/55 ± TAA Descending CFA 1 70 3 11
19/F/86 ± TAA Descending CFA 1 60 5 9
20/M/58 ± Traum. Rupture Descending CFA 1 70 15 8
21/F/65 ± Ruptured TAA Descending CFA 2 125 10 5
CFA ± Common Femoral Artery.TalentTM thoracic endoprosthesis;
1 simultaneous stent-graft for abdominal aortic aneurysm.
AneuRxTM stent-graft; other patients received the GoreTM thoracic Excluder.
Including operation time for bypass of aortic arch arteries.Patient died of respiratory failure; non-procedure-related complication.
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origin of the subclavian artery was treated success-
fully by placing a Palmaz stent, pushing the fabric
cover of the stent-graft somewhat backwards, leaving
the bare spring in place. Patient 15 was operated
19 years earlier because of aortic co-arctation, 7 years
earlier a reoperation was necessary because of a large
aneurysm at the native aortic arch. Now he presented
with a large false aneurysm at the distal anastomosis
between the aortic graft and descending aorta. This
aneurysm was successfully excluded by a thoracic
stent-graft, preventing a third thoracotomy.
We implanted thoracic stent-grafts for false aneur-
ysms in 2 patients with Marfan syndrome. Patient 10
underwent replacement of the aortic valve and
ascending aorta (Bental procedure) for an aortic
aneurysm 14 years earlier, followed by thoracoabdom-
inal aortic grafting 9 years later. At follow-up we
observed an aneurysm at the distal anastomosis of
the ascending aortic prosthesis, which was success-
fully sealed with a stent-graft. Patient 20 had an opera-
tion for scoliosis via anterior-lateral approach 20 years
earlier. On a routine X-ray examination by the ortho-
pedic surgeon, a saccular aneurysm of the thoracic
aorta was seen. A CT scan showed a close connection
between the aneurysm and retained material from the
previous osteosynthesis. The aneurysm was success-
fully excluded with a thoracic stent-graft and the
patient was discharged after 2 days (Fig. 2a and b).
The other patient who was treated for false aneur-
ysm (patient 3), was operated at age 16 for Steal
syndrome due to stenosis of the left subclavian artery.
This was resolved by a thrombo-endarterectomy
(TEA) of the left subclavian artery. When during
follow-up an asymptomatic aneurysm of the origin
of the subclavian artery was found, he underwent a
side-to-end carotid-subclavian bypass followed by
stent-grafting of the aortic arch. At follow-up the
aneurysm is now diminished from 4.5 to 3.7 cm.
Two patients had a mycotic aneurysm for which
they received antibiotical treatment (Vancomycin and
Ciprofloxacin). Patient 8 probably developed a mycotic
aneurysm due to previous Clostridium sepsis.
Impression of the aneurysm on the esophagus
caused an aortic-esophageal fistula. Stent-grafting of
the descending thoracic aorta successfully repaired
this aneurysm. Three days later, this procedure was
followed by a transhiatal esophagectomy.24 The
second patient had a mycotic aneurysm probably
due to Salmonellosis, based on physical examination
and anamnesis, although blood cultures were nega-
tive. Both patients, now 26 months after successful
exclusion of the aneurysm, show no signs of residual
infection. The patient with the esophageal rupture
needed a late right-sided mini thoracotomy for drain-
age of an aneurysm sac hygroma at 18 months.24
One patient with a ruptured descending aortic
aneurysm was referred to our hospital. Immediately,
2 thoracic stent-grafts were placed, followed by
evacuation of 1.5 l of blood from the right hemi-
thorax. She was discharged after 10 days (Fig. 3a±c).
Four patients (median age 48.5 years (19±58 years))
had a traumatic rupture of the descending thoracic
aorta.12 All these patients had concomitant lesions
due to the nature of the trauma. In 3 patients the
ruptured aneurysm was accompanied by multiple
Fig. 1. (a) AP chest X-ray of a patient with a TAA. The aortic arch is
seen next to the black arrow and the large aneurysm next to the
white arrow. (b) Detail of an oblique post operative chest X-ray. The
metal components of the endograft are clearly visible. The white
arrows point at the proximal and distal anchoring zones, the black
arrow shows the graft fully expanded at the site of the aneurysm.
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rib fractures. These patients were treated with
single stent-grafts. Due to concomitant lesions median
hospital stay was relatively long for this subgroup
(22.5 days (range 15±55 days)).
Stent-related complications
Stent-related and general complications are listed in
Table 3. In patient 11 we observed migration of the
stent-graft during deployment; this was treated by
placing a second stent-graft during the same proce-
dure. Unfortunately, 6 months postoperatively CT
angiography revealed a persisting type I endoleak.
This endoleak was successfully treated by coil emboli-
zation and thrombin injection, as measured by
unchanged volume of the aneurysm.
In patient 15 a type II endoleak was diagnosed at
6 months follow-up. Due to the complex vascular
Fig. 3. (a) Postoperative lateral chest X-ray of a patient with a
ruptured TAA. Two endografts were used to exclude the aneurysm.
(b). Axial CT image of the patient with the ruptured TAA made two
days after surgery. The hematothorax on the right side has been
drained, the bright metal components of the endograft are sur-
rounded by hematoma. (c) Axial image at the same position 3
months after surgery. The peri-aortal mass is shrinking.
Fig. 2. (a) Detail of postoperative chest X-ray of patient with Marfan
syndrome and operation for severe scoliosis. The material from the
osteosynthesis has caused a lesion of the aorta at the position of the
uppermost screw. This screw is compressing the endovascular graft.
(b) Detail from a lateral chest X-ray of the same patient.
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supply of the endoleak, it was impossible to exclude
the endoleak by coil embolization. We decided on a
conservative treatment and now, 9 months after the
discovery of the endoleak, there is no progression in
endoleak or aneurysm size.
Another early stent-related complication occurred
in patient number 6 with a TAA between T5±T9. A
few hours after surgery the patient complained of
pain in the left hemi-thorax without neurological
symptoms. Fourteen hours after the endovascular pro-
cedure, paralysis and paresis, respectively, of the left
and right leg and sensibility deficit from T10 down-
wards developed.25 Emergency conversion to conven-
tional surgery was performed. The stent-graft was
removed with consequent graft interposition with
revascularization of 3 intercostal arteries. After the
procedure, we observed gradual improvement of the
neurological deficit. Now, almost 3 years postopera-
tively, the patient can walk, with minimal paresis of
the upper leg muscles on the right side. His major
problem is chronic pain in the legs.
General complications
We observed no in-hospital or 30 day mortality. One
patient with a severe head injury and successful treat-
ment of a traumatic rupture of the aorta died 9 months
later in a nursing home due to pulmonary infection
and respiratory failure.
Two patients developed pneumonia, one requiring
reintubation in ICU. One patient developed a suture
granuloma in the right groin 4 months postopera-
tively. The acute endovascular procedure in patient
21 with a ruptured TAA was complicated by common
femoral artery intimal dissection for which a Dacron
interposition graft was placed. Postoperatively, this
patient suffered form cardiac arrhythmia with a tem-
porary, total AV block.
Discussion
Since stent-grafting avoids thoracotomy and cross-
clamping, the operative insult is markedly reduced
leading to a lower morbidity and mortality.19
Operation time, ICU and hospital stay were less
when compared to results from conventional surgery
from literature. Our results are comparable to recently
published reports.26
In our patients, preoperative imaging of the aortic
aneurysm was supplemented by additional SSP. This
digital reconstruction gives the surgeon a better per-
ception of the three-dimensional structure of the
aneurysm. However, creating the SSP reconstruction
is time consuming and its additional value to the CT
can be debated.
Migration of the stent-graft can occur either intra- or
postoperatively.27 In patient 11 intra-operative migra-
tion during deployment of the stent-graft was encoun-
tered. Probably, this reflects misdeployment rather
than stent migration. We had to place a second stent-
graft in this patient to improve the proximal seal.
Spinal cord ischemia occurs when the stent-graft
covers Adamkiewicz artery or other vital intercostal
arteries. Recently published early and mid-term stu-
dies of endovascular TAA repair have reported para-
plegia rates varying from 0±4%.28±32 In our series,
1 of the 23 patients had a partial reversible myelo-
pathy. We performed a thoracotomy with interposi-
tion graft, although this choice can be debated.
Various methods have been described to aid in the
prevention of spinal cord ischemia, such as medica-
tion, generalized33 or local hypothermia,34 hyperbaric
oxygen treatment,35 reattachment of intercostal
arteries and cerebrospinal fluid (CSF) drainage.36±39
CSF drainage is also used for reversal of paraplegia.40
Presumably, drainage of CSF to a pressure of less than
10 mmHg favorably alters the pressure gradient, thus
maintaining myelum perfusion. Thus, a re-thoracotomy
can be prevented.
Apart from the use of the thoracic aortic stent-graft
for elective aneurysms, we have used it for a variety of
other pathologies.
Traumatic ruptures of the aorta are often associated
with extensive accessory lesions due to the nature of
the trauma. Only 15±20% of the patients reach the
hospital alive.41 Of the patients reaching the operating
theatre alive, an average of 7.8% die during the opera-
tion, and another 13.5% in the postoperative period.42
In the acute phase of the blunt aortic trauma thora-
cotomy is associated with major blood loss and opera-
tion risks and can cause additional damage.13 As in
elective aneurysm repair, the minimal invasive endo-
vascular treatment in this patient group is a fast and
Table 3. Complications.
Complications Patients (n)
Stent-related complications
Migration 1
Endoleak 2
Spinal cord ischemia 1
Access dissection 1
General complications
In-hospital mortality 0
Pneumonia 2
Suture granuloma 1
Cardiac (arrythmia) 1
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relatively easy to perform procedure. A disadvantage
is that the time for optimal calculation of the stent-
graft length and diameter is reduced; on the other
hand, the endovascular procedure allows quick stabil-
ization of the patient. Mortality and morbidity rates in
a (semi-)elective phase are lower than in the acute
phase. So by placing a stent-graft, mortality might be
diminished, even if patients might need an endovas-
cular or open reintervention at a later stage due to
non-optimal fitting of the stent-graft.
For patients with anatomical difficult localization of
the pathology (e.g. aortic arch) or previous thoracic
surgery, an endovascular procedure is an improve-
ment in treatment saving patients a lengthy and diffi-
cult thoracotomy. Potential disadvantages of the
endovascular treatment must not be underestimated.
Lack of long-term results and prospective (rando-
mized) studies still prohibit unconditional implemen-
tation. Material deficits of predominantly abdominal
aortic stent-grafts have been reported.43±46 Although
the literature on thoracic stent deficits is still scarce,
device failures due to fabric tears and/or stent frac-
tures can be expected here as well. Fatigue fractures of
the stent frame are known to occur in both the Talent
and Gore thoracic graf ± a reason for W.L. Gore and
Associates to seize production of this stent-graft.
Despite this potential uncertainty about the mechan-
ical properties, it seems important that the endo-
vascular technology remains available for treating
patients with thoracic aortic pathology. Long-term
results are especially relevant in the relatively young
(trauma) patients.13
In conclusion, endovascular treatment of aneur-
ysms and traumatic ruptures of the thoracic aorta
after adequate patient selection is a feasible procedure
with an acceptable mortality and morbidity. In our
patients we achieved excellent short- and mid-term
results. The ability to treat otherwise inoperable
patients with a thoracic stent-graft is a definite benefit
over conventional treatment. The risk of neurological
complications appears to be equal to that of conven-
tional treatment. However, lack of long-term results
and randomized studies ask for caution. A multidisci-
plinary approach in specialized medical centers is
necessary.
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